Cyclopropanecarboxaldehyde → HCID 11706509, compound
Reaction equation
[NH2:1][C:2]1[C:3](=[O:35])[NH:4][C:5]2[C:10]([N:11]=1)=[C:9]([O:12][C:13]1[CH:18]=[C:17]([C:19]3[CH:24]=[CH:23][C:22]([C:25]([F:28])([F:27])[F:26])=[CH:21][CH:20]=3)[N:16]=[C:15]([N:29]3[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]3)[N:14]=1)[CH:8]=[CH:7][CH:6]=2.[CH:36]1([CH:39]=O)[CH2:38][CH2:37]1>>[NH2:1][C:2]1[C:3](=[O:35])[NH:4][C:5]2[C:10]([N:11]=1)=[C:9]([O:12][C:13]1[CH:18]=[C:17]([C:19]3[CH:24]=[CH:23][C:22]([C:25]([F:28])([F:27])[F:26])=[CH:21][CH:20]=3)[N:16]=[C:15]([N:29]3[CH2:34][CH2:33][N:32]([CH2:39][CH:36]4[CH2:38][CH2:37]4)[CH2:31][CH2:30]3)[N:14]=1)[CH:8]=[CH:7][CH:6]=2Participants
3
Procedure
The reaction of 3-amino-5-(2-(piperazin-1-yl)-6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yloxy)quinoxalin-2(1H)-one (27 mg, 0.056 mmol, Example 135) with cyclopropanecarboxaldehyde (59 mg, 0.279 mmol, Aldrich) under the conditions of Example 36 provided the title compound as an amorphous solid. MS (ESI, pos. ion) m/z: 538 (M+1).
Sources & evidence
- ORD record
- ord-1aa936d341574c2f83a84c1bc6d8c530
- Source dataset
- uspto-grants-2008_02
- Patent number
- US07335672B2
Reaction notes
Loading…